• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Current directions in chemotherapy for colorectal cancer.

作者信息

Inoue Yasuhiro, Miki Chikao, Kusunoki Masato

机构信息

Department of Gastrointestinal and Pediatric Surgery, Division of Reparative Medicine, Institute of Life Sciences, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu 514-8507, Japan.

出版信息

J Gastroenterol. 2006 Sep;41(9):821-31. doi: 10.1007/s00535-006-1873-3.

DOI:10.1007/s00535-006-1873-3
PMID:17048045
Abstract
摘要

相似文献

1
Current directions in chemotherapy for colorectal cancer.结直肠癌化疗的当前方向
J Gastroenterol. 2006 Sep;41(9):821-31. doi: 10.1007/s00535-006-1873-3.
2
Chemotherapy for advanced colorectal cancer. Does the evidence or the doctor have the greater influence?
BMJ. 2001 Jan 27;322(7280):233.
3
Recent advances in the treatment of metastatic colorectal cancer in Taiwan.台湾转移性结直肠癌治疗的最新进展
J Formos Med Assoc. 2011 Jan;110(1):1-3. doi: 10.1016/S0929-6646(11)60001-6.
4
Chemotherapy for colorectal cancer in the metastatic and adjuvant setting: past, present and future.转移性和辅助性结直肠癌的化疗：过去、现在与未来
Expert Rev Anticancer Ther. 2007 Apr;7(4):477-87. doi: 10.1586/14737140.7.4.477.
5
Molecular markers of chemotherapy in advanced colorectal cancer: back to square one.
Eur J Cancer. 2009 Jul;45(11):1902-3. doi: 10.1016/j.ejca.2009.05.018. Epub 2009 Jun 6.
6
[Pro and contra adjuvant chemotherapy in colorectal carcinoma].[结直肠癌辅助化疗的利弊]
Med Klin (Munich). 1996 Sep 15;91(9):609-11.
7
Neoadjuvant chemotherapy for patients with liver metastases from colorectal cancer.结直肠癌肝转移患者的新辅助化疗
Expert Rev Anticancer Ther. 2007 Jun;7(6):887-97. doi: 10.1586/14737140.7.6.887.
8
Tenth anniversary of bevacizumab in colorectal cancer: has it fulfilled its promise?
Future Oncol. 2014 Feb;10(2):149-52. doi: 10.2217/fon.14.6.
9
[Molecular biomarkers to predict outcome in colorectal cancer- current evidence and future perspectives].
Gan To Kagaku Ryoho. 2014 Nov;41(11):1367-71.
10
Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases.术前化疗对结直肠癌肝转移患者行大肝切除术风险的影响。
Ann Surg. 2006 Nov;244(5):833-5; author reply 835. doi: 10.1097/01.sla.0000243600.98464.a5.

引用本文的文献

1
Modified alginates for precision drug delivery: Advances in controlled-release and targeting systems.用于精准给药的改性藻酸盐：控释和靶向系统的进展
Int J Pharm X. 2025 Aug 25;10:100381. doi: 10.1016/j.ijpx.2025.100381. eCollection 2025 Dec.
2
Optimal use of current chemotherapy in multimodality therapy for advanced colorectal cancer.当前化疗在晚期结直肠癌多模式治疗中的优化应用。
Oncol Lett. 2012 Feb;3(2):363-368. doi: 10.3892/ol.2011.508. Epub 2011 Dec 1.

本文引用的文献

1
Second-look hepatectomy after 5FU arterial infusion in patients with primary unresectable hepatic colorectal metastases.
Int J Oncol. 1997 Jan;10(1):107-11.
2
Colorectal cancer: genetics of development and metastasis.结直肠癌：发生与转移的遗传学
J Gastroenterol. 2006 Mar;41(3):185-92. doi: 10.1007/s00535-006-1801-6.
3
Multicenter phase II study of fixed sequences of capecitabine combined with oxaliplatin or irinotecan in patients with previously untreated metastatic colorectal cancer.卡培他滨联合奥沙利铂或伊立替康固定方案用于既往未治疗的转移性结直肠癌患者的多中心II期研究。
Clin Colorectal Cancer. 2006 Mar;5(6):429-35. doi: 10.3816/ccc.2006.n.014.
4
Phase II study of combination therapy with S-1 and irinotecan in patients with advanced colorectal cancer.S-1与伊立替康联合治疗晚期结直肠癌的II期研究。
Ann Oncol. 2006 Jun;17(6):968-73. doi: 10.1093/annonc/mdl066. Epub 2006 Apr 7.
5
XELOX (capecitabine plus oxaliplatin) as first-line treatment for elderly patients over 70 years of age with advanced colorectal cancer.XELOX（卡培他滨联合奥沙利铂）作为70岁以上老年晚期结直肠癌患者的一线治疗方案。
Br J Cancer. 2006 Apr 10;94(7):969-75. doi: 10.1038/sj.bjc.6603047.
6
Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481).肝动脉灌注与全身治疗用于结直肠癌肝转移：一项关于疗效、生活质量和分子标志物的随机试验（CALGB 9481）
J Clin Oncol. 2006 Mar 20;24(9):1395-403. doi: 10.1200/JCO.2005.03.8166. Epub 2006 Feb 27.
7
Benefits and risks of palliative capecitabine based therapy to elderly patients with advanced colorectal cancer: Danish single centre experiences.基于卡培他滨的姑息治疗对老年晚期结直肠癌患者的益处和风险：丹麦单中心经验
Acta Oncol. 2006;45(1):67-76. doi: 10.1080/02841860500375213.
8
OPTIMOX1: a randomized study of FOLFOX4 or FOLFOX7 with oxaliplatin in a stop-and-Go fashion in advanced colorectal cancer--a GERCOR study.OPTIMOX1：一项关于晚期结直肠癌中采用FOLFOX4或FOLFOX7联合奥沙利铂以“停停走走”方式进行治疗的随机研究——一项GERCOR研究
J Clin Oncol. 2006 Jan 20;24(3):394-400. doi: 10.1200/JCO.2005.03.0106.
9
Advances in the treatment of metastatic colorectal cancer.转移性结直肠癌的治疗进展
Oncologist. 2005;10 Suppl 3:40-8. doi: 10.1634/theoncologist.10-90003-40.
10
What is the best sequence of chemotherapy in advanced colorectal cancer? Final results of a five-arm study.
Chemotherapy. 2006;52(1):20-2. doi: 10.1159/000090237. Epub 2005 Dec 9.